{"id":"NCT00409240","sponsor":"Providence VA Medical Center","briefTitle":"Multi-Targeted Cardiac Risk Intervention in Type 2 Diabetes","officialTitle":"Multi-Targeted Cardiac Risk Intervention in Type 2 Diabetes","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2006-10","primaryCompletion":"2008-06","completion":"2008-06","firstPosted":"2006-12-08","resultsPosted":"2014-04-11","lastUpdate":"2014-04-11"},"enrollment":103,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"NONE","primaryPurpose":"TREATMENT"},"conditions":["Diabetes","Hypertension","Dyslipidemia"],"interventions":[{"type":"OTHER","name":"MEDIC","otherNames":[]}],"arms":[{"label":"MEDIC Intervention","type":"EXPERIMENTAL"},{"label":"Usual Care","type":"NO_INTERVENTION"}],"summary":"Our study intends to test the efficacy of pharmacist-led group interventions on a weekly basis for 4-weeks, then on a monthly basis for 5 additional months to achieve concomitant reductions in hemoglobin A1c, lipids and blood pressure.","primaryOutcome":{"measure":"Percent of Patients Achieving Hemoglobin A1C Goal, LDL Cholesterol Goal, and Systolic Blood Pressure Goal From the Enrollment Until the End of the Study","timeFrame":"6 months","effectByArm":[{"arm":"MEDIC Intervention","deltaMin":40.8,"sd":null},{"arm":"Usual Care","deltaMin":20.4,"sd":null}],"pValues":[]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":false,"inclusionCount":5,"exclusionCount":4},"locations":{"siteCount":1,"countries":["United States"]},"refs":{"pmids":["22021025"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":0,"n":50},"commonTop":["Hypoglycemia","Infection","Lung cancer surgery",null]}}